Product Information
ENTECAVIR 0.5 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.2134 per EA under NDC 69097042602. Its NADAC has been published 493 times since Mar 15, 2017.
FDA first approved this application on Dec 6, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/1
Manufacturer
Cipla USA Inc.NDC
69097042602
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ENTECAVIRApproval Type
Generic (ANDA)
FDA Application
ANDA206872FDA Approved
12/6/2016
TE Code
AB
On Market Since
12/6/2016
Pharmacological Classes
Price Statistics
The NADAC for ENTECAVIR 0.5 MG TABLET has been published 493 times since Mar 15, 2017, and over the history we have for it it has declined 97.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2134 per EA |
|---|---|
| All-time high | $9.9327 (Apr 12, 2017) |
| All-time low | $0.2096 (May 20, 2026) |
| 52-week high | $0.2640 |
| 52-week low | $0.2096 |
| Median price | $0.9966 |
| Average price | $1.5458 |
| Largest weekly change | +48.1% (Jul 17, 2024) |
| Weeks tracked | 493 |
| Tracking since | Mar 15, 2017 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ENTECAVIR 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ENTECAVIR 0.5 MG TABLET, manufactured by Cipla USA Inc., is $0.2134 per EA (NDC 69097042602), effective Aug 19, 2026.
How has the price of ENTECAVIR 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ENTECAVIR 0.5 MG TABLET has declined 97.6%. It has been tracked across 493 weekly CMS publications since Mar 15, 2017.
What are the highest and lowest recorded NADAC prices for ENTECAVIR 0.5 MG TABLET?
Since Mar 15, 2017, the NADAC for ENTECAVIR 0.5 MG TABLET has ranged from a low of $0.2096 (May 20, 2026) to a high of $9.9327 (Apr 12, 2017), with a median of $0.9966 per EA.
Are there cheaper alternatives to ENTECAVIR 0.5 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ENTECAVIR 0.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ENTECAVIR 0.5 MG TABLET?
ENTECAVIR 0.5 MG TABLET (NDC 69097042602) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.